Servier Inks $1B Deal for Intarcia’s Implantable Diabetes Device

It’s been a big year for Intarcia Therapeutics. The Boston- and Hayward, CA-based firm raised a massive round of private financing for its experimental drug/device combo treatment for (Read more...)